StockIQ.techDaVita Inc. (DVA) Stock Analysis
Free AI-powered analysis and research for DaVita Inc. stock
Sector: Healthcare
DVA snapshot
Data as of 4 Nov 2026 close. Updated daily.
DaVita Inc. scores 84/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 60% of its 52-week range, up 57.7% over the past year. Latest reported figures show a profit margin of 6.0%, return on equity of 88.5% and revenue growth of +5.2%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +9
- MACD Bullish: +8
- High Debt (12.42 D/E): -10
- Weak Liquidity (1.47 Current Ratio): -5
- Excellent ROE (88.5%): +8
- Low P/B (-16.01): +5
- Above MA200: +4
- Strong Rise (+57.7% over 1 year): +10
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full DVA report
DaVita Inc. (DVA) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze DVA Now →📰 Latest Update
DaVita (DVA) Q3 2026 Earnings Call Transcript
Fri, October 30, 2026 at 2:29 PM UTC 2 min read
DaVita (DVA) reported its Q3 2026 earnings, showcasing a solid performance with revenue growth driven by increased patient volumes and improved operational efficiencies. The company’s focus on expanding its outpatient services and enhancing care delivery is crucial for sustaining long-term growth. For investors, this positive trajectory indicates potential for continued profitability and reinforces confidence in DaVita's strategic initiatives amid a competitive healthcare landscape.